- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 33.27M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 26.79M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $7.97M |
| Capex | Q1 2026 · Mar 31, 2025 | $8.9M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$26.21M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$8.43M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $16.05M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $24.81M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $91.21M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $112.93M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $3.72M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$11.69M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $68.52M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $72.29M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $91.65M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $98.06M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $64.43M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $93.77M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $182.86M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $210.99M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.78 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$0.88 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.78 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$0.88 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $18.13M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $17.65M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $8.7M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $8.66M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$25.84M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$23.52M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$24.58M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$28.29M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $6.31M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $8.71M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $9.53M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $15.16M |
| Revenue | Q1 2026 · Mar 31, 2026 | $15.83M |
| Revenue | Q1 2026 · Mar 31, 2025 | $23.88M |